Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-08-14
2007-08-14
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S635000, C514S452000, C514S464000, C556S467000, C556S467000, C556S467000, C549S365000, C549S462000
Reexamination Certificate
active
10716283
ABSTRACT:
Biguanide and dihydrotriazine derivatives, preferably substituted asymmetrical imidodicarbonimidic diamides derived from hydroxylamines, and compositions containing biguanide and dihydrotriazine derivatives are disclosed. In addition, methods of using the biguanide and dihydrotriazine derivatives, inter alia, as antimicrobial agents and methods of using the dihydrotriazine derivatives in biological assays are disclosed. Methods of making the biguanide and dihydrotriazine derivatives are also disclosed.
REFERENCES:
patent: 3723429 (1973-03-01), Mamalis et al.
patent: 4179562 (1979-12-01), Ponsford
patent: 4232022 (1980-11-01), Ponsford
patent: 5300503 (1994-04-01), Peake et al.
patent: 5322858 (1994-06-01), Canfield et al.
patent: 5538812 (1996-07-01), Lee et al.
patent: 1 250 531 (1971-10-01), None
Snyder et al., J. Med. Liban 48(4): 208-214, 2000.
Bergeron, R.J., et al., “Mild oxidation of alkyl halides,”J. Org. Chem., 1979, 44(11), 1835-1839.
Carey, F.A., et al., Advanced Organic Chemistry, Part B: Reactions and Synthesis, 3rdEd.,Plenum Press, New York, 1990, 588-591.
Crowther, A.F., “Synthetic antimalarials. Part XXIX. The preparation of some N1-aryl-N2-alkyl-N5-alkyl- and -dialkyl-diguanides,”J. Chem. Soc., 1948, 1636-1645.
Curd, F.H.S., et al., “Synthetic antimalarials. Part XXVIII. An alternative route to N1-aryl-N5-alkyldiguanides,”J. Chem. Soc., 1948, 1630-1635.
Davidson, J.S., “A preparation ofN-alkyl-N-cyano-S-methylisothioureas,”Chemistry and Industry, Nov. 27, 1965, 1977-1978.
Gennaro, A.R. (Ed.), Remington's Pharmaceutical Sciences, 17thEd.,Mack Publishing Co., Easton, PA, 1985.
Greene, T.W., et al., Protective Groups in Organic Synthesis, 2ndEd.,John Wiley&Sons, Inc., 1991, 117-118.
Jensen, N.P., et al., “Phenoxypropoxybiguanides, prodrugs of DHFR—inhibiting diaminotriazine antimalarials,”J. Med. Chem., 2001, 44, 3925-3931.
Knight, D.J., et al., “The antimalarial activity of N-benzyloxydihydrotriazines,”Annals. of Tropical Med.&Parasitol., 1980, 74(4), 393-404.
Knight, D.J., et al., “The antimalarial activity of N-benzyl-oxydihydrotriazines,”Annals of Trop. Med.&Parasitol., 1982, 76(1), 9-14.
Larock, R.C., Comprehensive Organic Transformation,:VCH Publishers, New York, 1989, 353-363.
Onori, E., et al., “Recent acquisitions on chemotherapy and chemoprophylaxis of malaria,”Ann. 1stSuper Sanita., 1989, 25(4), 659-673.
The PCT International Search Report dated May 6, 2004 (PCT/US03/37511).
Jacobus David P.
Jensen Norman P.
Schiehser Guy A.
Shieh Hong-Ming
Terpinski Jacek
Balasubramanian Venkataraman
Jacobus Pharmaceutical Company, Inc.
LandOfFree
Biguanide and dihydrotriazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biguanide and dihydrotriazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biguanide and dihydrotriazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3877992